• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Desloratadine – Trima Tablets
    / Trima


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    15 X 5 mg

    not in the basket chart 48793 16041

    Tablets

    30 X 5 mg

    not in the basket chart 48794 7904

    Related information


    Dosage

    One tablet once a day.
    This drug is not intended for children under 12 years old.


    Indications

    Desloratadine-Trima tablets are indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with:
    – allergic rhinitis
    – urticaria


    Contra-Indications

    Hypersensitivity to any of the medicine’s ingredients or to loratadine.
    Children under 12 years old.


    Special Precautions

    Impaired  kidney function. In rare cases, use of the preparation may cause drowsiness that may affect the ability to drive and use machines.
    Please refer to the license holder for further details.


    Side Effects

    Headache, dry mouth, fatigue, fever, diarrhea, insomnia.
    Please refer to the license holder for further details.


    Pregnancy and Lactation

    It is not recommended to use this preparation if you are pregnant or breastfeeding.
    Please refer to the license holder for further details.          


    Manufacturer
    Trima Israel Pharmaceutical Products Maabarot Ltd. Israel
    CLOSE